Chameleon Biosciences

Chameleon Biosciences develops an evading viral vector platform designed to deliver gene therapies while bypassing the human immune system. The company targets pharmaceutical and biotechnology firms to solve the problem of pre-existing immunity in patients, which often prevents successful gene therapy treatment.